Centene Corporation CNC
At closeNov 4, 2026, 8:27 AM EST
Pre-market · Nov 4, 8:27 AM ET
- YTD
- +63.99%
- 1 year
- +86.87%
- Market cap
- 33.41B
- Revenue (ttm)
- 180.41B
- Profit margin
- 0.81%
- EPS (ttm)
- 2.91
- Shares out
- 495.07M
- P/E ratio
- 23.19
- Forward P/E
- 12.19
- YTD return
- +63.99%
- 1-year return
- +86.87%
- Volume
- 4.72M
- Avg volume
- 4.49M
- Open
- 66.12
- Previous close
- 66.53
- Day's range
- 66.11 – 67.49
- 52-week range
- 31.63 – 72.50
- Beta
- 1.08
- Analysts
- Buy
- Price target
- 74.50 (+10.4%)
- Earnings date
- Feb 5, 2027
2Y +3.66 (+5.73%)
Key statistics
- Enterprise value
- 24.99B
- PEG ratio
- 0.78
- Price / sales
- 0.19
- Price / book
- 1.50
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.20%
- Free cash flow
- 3.08B
- Total cash
- 23.59B
- Total debt
- 15.54B
- Return on equity
- 6.74%
- Short % of float
- 2.53%
- 50-day average
- 66.14
- 200-day average
- 55.45
Analyst view
Consensus: buy
- Target (low)
- 56.00
- Target (mean)
- 74.50
- Target (high)
- 85.00
- Strong buy1
- Buy7
- Hold12
- Sell1
- Strong sell0
Next earnings
Feb 5, 2027
Expected Feb 5, 2027. Consensus EPS estimate -1.12.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 5, 2027 | Dec 30, 2026 | -1.14 | — | — | — |
| Oct 27, 2026 | Sep 30, 2026 | 0.0957 | 0.58 | +0.48 | +506.06% |
| Jul 28, 2026 | Jun 30, 2026 | 1.09 | 2.51 | +1.42 | +130.28% |
| Apr 28, 2026 | Mar 31, 2026 | 2.23 | 3.37 | +1.14 | +51.12% |
| Feb 6, 2026 | Dec 31, 2025 | -1.22 | -1.19 | +0.03 | +2.46% |
| Oct 29, 2025 | Sep 30, 2025 | -0.14475 | 0.50 | +0.64 | +445.42% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Truist Securities | reit | Buy | Buy |
| Oct 30, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | JP Morgan | main | Neutral | Neutral |
| Oct 28, 2026 | UBS | main | Neutral | Neutral |
| Oct 28, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Oct 28, 2026 | Barclays | main | Overweight | Overweight |
About Centene Corporation
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- centene.com
News
4 GARP Stocks to Buy Now as Volatility Fuels Value vs. Growth Debate 
Truist Securities Reiterates Buy on Centene, Raises Price Target to $82 
Wells Fargo Maintains Equal-Weight on Centene, Raises Price Target to $75 - JP Morgan Maintains Neutral on Centene, Raises Price Target to $75
Morgan Stanley Maintains Equal-Weight on Centene, Raises Price Target to $71 
Are You Looking for a Top Momentum Pick? Why Centene (CNC) is a Great Choice - Barclays Maintains Overweight on Centene, Raises Price Target to $82
Why Centene (CNC) is a Top Value Stock for the Long-Term 
Should Value Investors Buy Centene (CNC) Stock? 
Coca-Cola To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Wednesday
Your note
Sign in to keep a note on CNC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ASHER ANDREW LYNN | Chief Financial Officer | Stock Award(Grant) | Jan 25, 2026 | 831,216 |
| BURDICK KENNETH A | Director | Sale | Jun 9, 2026 | 283,584 |
| CASSO KATIE | Officer | Stock Award(Grant) | Jan 25, 2026 | 122,371 |
| DALLAS HIRAM JAMES | Director | Stock Award(Grant) | May 11, 2026 | 49,567 |
| EPPINGER FREDERICK H | Director | Stock Award(Grant) | Sep 29, 2026 | 370,402 |
| KOSTER CHRISTOPHER A. | General Counsel | Sale | Aug 25, 2026 | 248,954 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.37% | 41,446,046 | 2.80B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.36% | 31,478,140 | 2.12B | Jun 29, 2026 |
| AQR Capital Management, LLC | 5.79% | 28,678,701 | 1.94B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.52% | 22,352,704 | 1.51B | Jun 29, 2026 |
| State Street Corporation | 4.44% | 21,965,370 | 1.48B | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.69% | 13,309,729 | 898.14M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 15,674,974 | 1.06B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.46% | 12,157,702 | 820.40M | Jun 29, 2026 |
| HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark Select Fund | 1.52% | 7,525,000 | 507.79M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 6,582,063 | 444.16M | Sep 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.24% | 6,149,030 | 414.94M | Jul 30, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.23% | 6,089,434 | 410.92M | Aug 30, 2026 |